Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Inflammation Amino Acids Cardio-Vascular Genetic Research

Possible Unexpected Atherosclerosis Treatment

1 year, 1 month ago

6020  0
Posted on Jan 31, 2020, 3 p.m.

According to a recent study published in the journal Cell Metabolism from Columbia University researchers, the compound responsible for one of the most putrid odors to be smelled may also be a possible treatment for atherosclerosis and other chronic inflammatory diseases.

The unusual discovery regarding putrescine, which is responsible for the smell of decomposing flesh, stems from investigations into the body’s process for removing dead cells using white blood cell macrophages that digest dead cells.

"It's estimated that a billion cells die in the body every day, and if you don't get rid of them, they can cause inflammation and tissue death," says Ira Tabas, MD, Ph.D., the Richard J. Stock Professor of Medicine and professor of pathology & cell biology (in physiology & cellular biophysics) at Columbia University Vagelos College of Physicians and Surgeons. "Removing these dead cells by a process called 'efferocytosis' (from the Latin 'to carry to the grave') is one of the body's most important functions."

Typically the efferocytosis process is initiated within moments of cell death, but studies suggest that this task becomes impaired with atherosclerosis which promotes the accumulation of plaques. To investigate the process further the researchers set up human macrophages and dying cells in a dish to observe how this process unfolds; this is when the role of putrescine was revealed, according to the researchers macrophages reclaim arginine and other amino acids from engulfed dead cells and use an enzyme to convert arginine into putrescine, which then activates Pac1 proteins that signal macrophages to eat more dead cells.

Findings suggest that atherosclerosis may be partly related to putrescine, to investigate the researchers selected mice with the condition. Mice with worsening atherosclerosis were found to have shortened supplies of putrescine because they were lacking in enough arginase-1 to make the compound. 

"But when we put putrescine in the animals' drinking water, their macrophages got better at eating dead cells and the plaques improved. Fortunately, when you dissolve putrescine into water, at least at the dosages needed to improve the plaques, it no longer gives off its odor. The mice drank it without any problem and show no signs of sickness," says Ira Tabas, MD, Ph.D.

“Of course we do not yet know the feasibility and safety of using low-dose putrescine to ward off atherosclerotic heart disease and other diseases driven by defective efferocytosis. However, the study shows the potential of treating heart disease with compounds that help macrophages eat dead cells and that are currently in clinical trials for other indications."

WorldHealth Videos

WorldHealth Sponsors